Novel Glucose-Lowering Therapies in the Setting of Solid Organ Transplantation
{{output}}
Post-transplant diabetes mellitus is a frequent consequence of or a pre-existing comorbidity in solid organ transplantation (SOT) that is associated with greater morbidity and mortality. Novel glucose-lowering agents that have been shown to have cardiovascular... ...
